Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
PREXISE-L
Pipeline
People
Culture
Careers
News
Careers
Publications
Blog
Terms of Use
Private Policy
ddd
Company
Novelty Nobility
Leadership
SAB
Contact Us
Platform
PREXISE-D
PREXISE-L
Pipeline
People
Culture
Careers
News
Careers
Publications
Terms of Use
Private Policy
PREXISE-D, Fit-for-Purpose
Antibody Design & Discovery
Learn more
Overcoming Drug Resistance
with Antibody-Drug Conjugate
Learn more
Bringing a Beautiful Moment of
Eye Contact to Everyone
Learn more
NEWS
[팜뉴스] 에피바이오텍-노벨티노빌리티, 탈모 항체치료제 개발 협약
[팜뉴스] 기초물질 발견에서 신약개발 응용까지…산학연 교류의 장 '하이원 심포지아'...
[한국경제신문] 노벨티노빌리티, 삼진제약과 ADC 신약 공동개발 협약
[한국대학신문] [창업하는 교수들] ②박상규 노벨티 노빌리티 대표 “8800억 원 규모 기술 이전 성공…신약...
[Mergermarket] Novelty Nobility plans USD 40m pre-IPO to discover novel drug candidates -CFO